LivaNova LIVN
NASDAQ LIVN
$78.96 -1.74 (-2.16%)
As of: Sep 9, 2026 · 3:59 PM EDT

LivaNova (LIVN) Operating Margin Growth (5y) (2021 - 2026)

Analysis

LivaNova (LIVN) Operating Margin Growth (5y) (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn
9 Steris 21.90 Bn 21.43 Bn 684.20 Mn
10 LivaNova 4.51 Bn 3.99 Bn 273.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2,638.00
Mar 31, 2026 1,375.00
Dec 31, 2025 10,418.00
Sep 30, 2025 1,824.00
Jun 30, 2025 2,456.00
Mar 31, 2025 1,558.00
Dec 31, 2024 6,157.00
Sep 30, 2024 161.00
Jun 30, 2024 2,339.00
Mar 31, 2024 1,379.00
Dec 31, 2023 6,472.00
Sep 30, 2023 367.00
Jun 30, 2023 -160.00
Mar 31, 2023 -589.00
Dec 31, 2022 -173.00
Sep 30, 2022 -6,419.00
Jun 30, 2022 164.00
Mar 31, 2022 -475.00
Dec 31, 2021 1,512.00
Sep 30, 2021 -625.00